Groupe Hospitalo-Universitaire Caremeau; Service Neurologie

Nîmes 30029

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis, Primary Progressive

Studies at this site

• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed